logo
Select company
Select metric
$ 2.41MNet Cash Flow - Financing
VS
Market
42
Sector
59
Industry
68
History
58
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

YMAB

Company Name

Y-MABS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Y-MABS THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

YMAB - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 2.41M
3/31/2025$ 3.84M
12/31/2024$ 4.31M
9/30/2024$ 3.42M
6/30/2024$ 2.45M
3/31/2024$ 688K
12/31/2023$ 100K
9/30/2023$ 0
6/30/2023$ 52K
3/31/2023$ 52K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • Y-MABS THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 135.29M.
  • Over the past 5 years, Y-MABS THERAPEUTICS INC's average CF - Financing has been $ 29.64M.
  • The median CF - Financing for Y-MABS THERAPEUTICS INC during this period was $ 2.21M
  • Y-MABS THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 135.29M.
  • The lowest CF - Financing recorded by Y-MABS THERAPEUTICS INC in the same timeframe $ 0

Y-MABS THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
ADCT : ADC THERAPEUTICS SA $ 92.06MNKTR : NEKTAR THERAPEUTICS $ 314KKURA : KURA ONCOLOGY INC $ 3.67MLXRX : LEXICON PHARMACEUTICALS INC $ -46.59MTRDA : ENTRADA THERAPEUTICS INC $ 2.08MXOMA : XOMA ROYALTY CORP $ -14.99MSAGE : SAGE THERAPEUTICS INC $ 1.12MCDXS : CODEXIS INC $ 59.3MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ 1.3MSGMO : SANGAMO THERAPEUTICS INC $ 43.54M

Similar metrics to CF - Financing:

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

YMAB - Net Cash Flow - Financing, Last 5 years

$ 0

Minimum

Sep 30, 2023

$ 135.29M

Maximum

Sep 30, 2020

$ 29.64M

Average

$ 2.21M

Median

CF - Financing Benchmark Analysis

 The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.89M with a standard deviation of $ 118.55M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -365.75M
max$ 365M
average$ -6.89M
median$ 314K
std$ 118.55M